However, we did not find any association between lymphocyte infiltrations and the overall survival of CRC patients, although high FoxP3+ T lymphocyte infiltrations in the tumor invasive margins resulted in an increased overall survival of 14 months. The gene discussed is FOXP3; the disease is colorectal carcinoma.